Epidemiological Aspects of Insomnia Research

  • M. Partinen
Conference paper


Insomnia is a common sleep disorder, and sleeping pills are commonly prescribed drugs. This chapter presents no new data on the prevalence of chronic insomnia or the incidence of transient insomnia but only a very short and fragmentary note about the quality of hypnotics research from a single point of view.


Randomize Clinical Trial Chronic Insomnia Hypnotic Drug Epidemiological Aspect Continent Ileostomy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Allen RP, Mendels J, Nevins DB, Chernik DA, Hoddes E (1987) Efficacy without tolerance or rebound insomnia for midazolam and temazepam after use for one to three months. J Clin Pharmacol 27: 768–775PubMedGoogle Scholar
  2. Anderson AA (1987) Zopiclone and nitrazepam, a multicenter placebo controlled comparative study of efficacy and tolerance in insomniac patients in general practice. Sleep 10 (Suppl 1): 54–62PubMedGoogle Scholar
  3. Autret E, Maillard F, Autret A (1987) Comparison of the clinical hypnotic effects of zopiclone and triazolam. Eur J Clin Pharmacol 31: 621–623PubMedCrossRefGoogle Scholar
  4. Billiard M, Besset A, de Lustrac C, Brissaud L (1987) Dose-response effects of zopiclone on night sleep and on nighttime and daytime functioning. Sleep 10 (Suppl 1): 27–34PubMedGoogle Scholar
  5. Bulbitt CJ (1987) Confidence intervals. Lancet 1: 494–497CrossRefGoogle Scholar
  6. Castleden CM, Aleen JG, Altman J, St John-Smith P (1987) A comparison of oral midazolam, nitrazepam and placebo in young and elderly subjects. Eur J Clin Pharmacol 32: 253–257PubMedCrossRefGoogle Scholar
  7. CDC (Consensus Development Conference) (1984) Drugs and insomnia. Consensus Development Conference, Summary, vol 4, no 10. US Department of Health and Human Services. National Institutes of HealthGoogle Scholar
  8. Gardner MJ, Altman DG (1988) Estimating with confidence. Br Med J 296: 1210–1211CrossRefGoogle Scholar
  9. Goldenberg F (1985) Advantages and disadvantages of different benzodiazepines in chronic insomnia. In: Koella WP, Rüther E, Schulz H (eds) Sleep 84. Fischer, Stuttgart, pp 56–59Google Scholar
  10. Kahn HA (1983) An introduction to epidemiologic methods. Oxford University Press, New YorkGoogle Scholar
  11. McClure DJ, Walsh J, Chang H, Olah A, Wilson R, Pecknold JC (1988) Comparison of lorazepam and flurazepam as hypnotic agents in chronic insomniacs. J Clin Pharmacol 28: 52–63PubMedGoogle Scholar
  12. McLeod RS, Cohen Z, Taylor DW, Cullen JB (1986) Single-patient randomised clinical trial. Use in determining optimum treatment for patient with inflammation of Kock continent ileostomy reservoir. Lancet 1: 726–728PubMedCrossRefGoogle Scholar
  13. Miettinen OS (1985) Theoretical epidemiology. Principles of occurrence research in medicine. Wiley, New YorkGoogle Scholar
  14. Nicholson AN, Stone BM (1987) Efficacy of zopiclone in middle age. Sleep 10 (Suppl 1): 35–39PubMedGoogle Scholar
  15. Overstall PW, Oldman PN (1987) A comparative study of lormetazepam and chlormethiazole in elderly in-patients. Age Ageing 16: 45–51PubMedCrossRefGoogle Scholar
  16. Partinen M, Eskelinen L, Tuomi K (1985) Epidemiology of insomnia: environmental factors. In: Koella WP, Rüther E, Schulz H (eds) Sleep’84. Fischer, Stuttgart, pp 42–44Google Scholar
  17. Rothman KJ (1986) Modern epidemiology. Little, Brown, BostonGoogle Scholar
  18. Schlesselman JJ (1982) Case-control studies. Design, conduct, analysis. Oxford University Press, New YorkGoogle Scholar
  19. Simonoff EA, Stores G (1987) Controlled trials of trimeprazine tartrate for night waking. Arch Dis Child 62: 253–257PubMedCrossRefGoogle Scholar
  20. Wheatley D (1986) Insomnia in general practice: the role of temazepam and a comparison with zopiclone. Acta Psychiatr Scand 332 (Suppl): 142–148CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1990

Authors and Affiliations

  • M. Partinen
    • 1
  1. 1.Department of NeurologyUniversity of HelsinkiHelsinkiFinland

Personalised recommendations